Screener
Sarepta Therapeutics, Inc. SRPT Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating income (loss) | 13,291 | 115,577 | 371,724 | (184,809) |
| Other (loss) income, net: | ||||
| Other (expense) income, net | (15,040) | 38,061 | (30,299) | (45,071) |
| (Loss) income before income tax expense (benefit) | (1,749) | 153,638 | 341,425 | (229,880) |
| Income tax expense (benefit) | 3,141 | (43,254) | 15,356 | 20,736 |
| Net (loss) income | $(4,890) | $196,892 | $326,069 | $(250,616) |
| Other comprehensive (loss) income: | ||||
| Unrealized (losses) gains on investments, net of tax | (444) | (85) | (837) | 167 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s pre-tax income?
- Sarepta Therapeutics, Inc. (SRPT) reported pre-tax income of -$1.75M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s pre-tax income changed year-over-year?
- Sarepta Therapeutics, Inc.'s pre-tax income decreased by 101.1% year-over-year, from $153.64M to -$1.75M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Sarepta Therapeutics, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude